A detailed history of Global Retirement Partners, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Global Retirement Partners, LLC holds 432 shares of UTHR stock, worth $155,895. This represents 0.0% of its overall portfolio holdings.

Number of Shares
432
Previous 289 49.48%
Holding current value
$155,895
Previous $92,000 67.39%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$311.04 - $363.55 $44,478 - $51,987
143 Added 49.48%
432 $154,000
Q2 2024

Jul 23, 2024

BUY
$228.26 - $319.04 $12,554 - $17,547
55 Added 23.5%
289 $92,000
Q1 2024

Apr 23, 2024

SELL
$210.76 - $249.51 $1,686 - $1,996
-8 Reduced 3.31%
234 $53,000
Q4 2023

Jan 18, 2024

BUY
$214.88 - $256.94 $6,016 - $7,194
28 Added 13.08%
242 $53,000
Q3 2023

Oct 13, 2023

BUY
$211.82 - $248.24 $8,260 - $9,681
39 Added 22.29%
214 $48,000
Q2 2023

Jul 20, 2023

SELL
$205.19 - $232.99 $10,054 - $11,416
-49 Reduced 21.88%
175 $38,000
Q1 2023

May 05, 2023

BUY
$212.99 - $276.17 $31,735 - $41,149
149 Added 198.67%
224 $50,000
Q4 2022

Feb 13, 2023

BUY
$205.95 - $280.43 $411 - $560
2 Added 2.74%
75 $20,000
Q3 2022

Nov 03, 2022

BUY
$203.3 - $244.17 $1,219 - $1,465
6 Added 8.96%
73 $17,000
Q2 2022

Jul 15, 2022

BUY
$174.81 - $241.14 $5,244 - $7,234
30 Added 81.08%
67 $16,000
Q1 2022

Jul 14, 2022

BUY
$166.16 - $213.96 $6,147 - $7,916
37 New
37 $8,000
Q4 2021

Jan 21, 2022

SELL
$184.32 - $216.08 $6,451 - $7,562
-35 Closed
0 $0
Q1 2021

Apr 14, 2021

BUY
$153.94 - $174.85 $5,387 - $6,119
35 New
35 $6,000
Q1 2018

Aug 10, 2018

SELL
$107.21 - $151.94 $5,360 - $7,597
-50 Closed
0 $0
Q4 2017

Aug 13, 2018

BUY
$118.58 - $151.28 $5,929 - $7,564
50
50 $7,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Global Retirement Partners, LLC Portfolio

Follow Global Retirement Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Retirement Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Retirement Partners, LLC with notifications on news.